KICK-IN GOAL LINKED TO WORST OF WITH EARLY REDEMPTION - SIEMENS/ROCHE GS/BAYER/NOVARTIS N Share Price

Certificat

KPCGDU

CH1298102034

Market Closed - Swiss Exchange 16:20:00 28/06/2024 BST
81.4 CHF +1.31% Intraday chart for KICK-IN GOAL LINKED TO WORST OF WITH EARLY REDEMPTION - SIEMENS/ROCHE GS/BAYER/NOVARTIS N
Current month-7.76%
1 month-7.76%
Date Price Change
28/06/24 81.4 +1.31%
25/06/24 80.35 +1.13%
24/06/24 79.45 -0.19%
21/06/24 79.6 +0.51%

Delayed Quote Swiss Exchange

Last update June 28, 2024 at 04:20 pm

More quotes

Static data

Product typesonstige Zertifikate
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer UBS
KPCGDU
ISINCH1298102034
Date issued 08/11/2023
Maturity 08/05/2025 (313 Days)
Parity 1 : 1
Emission price 100 CHF
Emission volume N/A
Settlement Barausgleich
Currency CHF

Technical Indicators

Highest since issue 94.25 CHF
Lowest since issue 78.15 CHF
Spread 10 CHF
Spread %1.21%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.5 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.44%
Consensus
  1. Stock Market
  2. Certificates
  3. KPCGDU Certificat